Discovery of Novel Respiratory Viruses Causing Influenza-Like Illness in Healthy Australian Adults Aged 18 to 64 Years. This work will inform our understanding of the causes of acute respiratory illnesses in Australia at the present time by looking for both known and previously undiscovered respiratory viruses. Increasing the knowledge base regarding causes of disease will have downstream relevance for health policy planners seeking to assess the burden of disease due to different causes. Early ....Discovery of Novel Respiratory Viruses Causing Influenza-Like Illness in Healthy Australian Adults Aged 18 to 64 Years. This work will inform our understanding of the causes of acute respiratory illnesses in Australia at the present time by looking for both known and previously undiscovered respiratory viruses. Increasing the knowledge base regarding causes of disease will have downstream relevance for health policy planners seeking to assess the burden of disease due to different causes. Early identification and description of new diseases will allow pre-emptive evaluation of new public health threats. This information will help to ensure availability and marketability of vaccines to prevent infection.Read moreRead less
Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This inform ....Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This information will provide the basis for tailoring treatment to a patients needs. It is anticipated that marketing of the PD GeneChip within Australia and overseas may produce revenue of at least $40 million annually.Read moreRead less
A high throughput Grid based environment for real time bio-medical imaging. Together with Leica, we will build a virtual microscope facility that will provide substantial functionality not currently available in Australia. This facility will have major national and international impact on bio-medical imaging. The software solutions and infrastructure, developed as part of this program will have considerable commercial and strategic value in their own right. One guaranteed avenue for exploitation ....A high throughput Grid based environment for real time bio-medical imaging. Together with Leica, we will build a virtual microscope facility that will provide substantial functionality not currently available in Australia. This facility will have major national and international impact on bio-medical imaging. The software solutions and infrastructure, developed as part of this program will have considerable commercial and strategic value in their own right. One guaranteed avenue for exploitation of the software will clearly be through our industry partner, Leica. Importantly, our proposal consolidates a critical mass of expertise connecting biomedical with computer science, thereby addressing a well-recognised constraint that to date has limited their national and international impact.Read moreRead less
Novel Self Assembled Particle Systems as a Key to Next Generation Biosensor Technology. Development and commercialisation of products utilising nanotechnology is crucial to future wealth creation for Australia. The translational research in this proposal will progress innovative concepts in nanotechnology-based biosensors, with potential for substantial improvements in disease diagnosis, leading to more economical and timely therapy. The products that arise from this research will also provide f ....Novel Self Assembled Particle Systems as a Key to Next Generation Biosensor Technology. Development and commercialisation of products utilising nanotechnology is crucial to future wealth creation for Australia. The translational research in this proposal will progress innovative concepts in nanotechnology-based biosensors, with potential for substantial improvements in disease diagnosis, leading to more economical and timely therapy. The products that arise from this research will also provide further employment for Australians, building on Universal Biosensor’s proven record of commercialization in Australia. The project will lead to training of Australian researchers in nanotechnology and in utilization of key Australian science infrastructure including the Australian Synchrotron and the Melbourne Centre for Nanofabrication.Read moreRead less
Development of an ultrasensitive assay for human prion proteins. The aim of this work is to enable the detection of prion proteins in human blood and other tissues. The assay system to be developed will detect much lower levels of these disease-causing proteins than is possible at present; it will be more rapid and will measure prion protein levels more accurately than existing assays. The outcome of the work is expected to facilitate the production and certification of prion-free blood and bl ....Development of an ultrasensitive assay for human prion proteins. The aim of this work is to enable the detection of prion proteins in human blood and other tissues. The assay system to be developed will detect much lower levels of these disease-causing proteins than is possible at present; it will be more rapid and will measure prion protein levels more accurately than existing assays. The outcome of the work is expected to facilitate the production and certification of prion-free blood and blood products. Prions cause Bovine Spongiform Encaphalopathy and Creutzfeld Jacob Disease and attempts to control of these diseases would be greatly abetted by an optimal test for the disease-causing agent.Read moreRead less
Fabrication and Application of Ion-Sensors Based on the Voltammetry of Nanocrystals Adhered to Electrode Surfaces. A significant need exists for the low cost determination of cations and anions in biologically (blood, urine), industrially (process streams) and environmentally (rivers, lakes) important fluids. In this project, skills in sensor design, scientific instrumentation, materials science, electrochemistry and analytical science provided by a consortium of scientists at Monash University ....Fabrication and Application of Ion-Sensors Based on the Voltammetry of Nanocrystals Adhered to Electrode Surfaces. A significant need exists for the low cost determination of cations and anions in biologically (blood, urine), industrially (process streams) and environmentally (rivers, lakes) important fluids. In this project, skills in sensor design, scientific instrumentation, materials science, electrochemistry and analytical science provided by a consortium of scientists at Monash University, the Victorian Institute for Chemical Sciences, Oxford Biosensors and Oxford University will be integrated to fabricate and develop applications of commercially viable ion-sensing systems. The principles to be utilised are based on novel forms of voltammetry of nanocrystals adhered to electrode surfaces.Read moreRead less
Radio-magnetic nanoparticles as bimodal positron emission tomography/magnetic resonance imaging contrast agents for dendritic cell tracking. Biomedical imaging is limited by a lack of commercial dual-mode contrast agents, which may be simultaneously used for magnetic resonance (MR) and positron emission tomography (PET) imaging. This project will develop a nanotechnology-based biocompatible dual-mode contrast agent for simultaneous PET and MR imaging, reducing associated side effects.
Quantitative measurement of Schizophrenia using Electrovestibulography. Schizophrenia was estimated to cost approximately $1.85billion in 2001 (0.3% of GDP and nearly $50k for each of the 37,000 Australians with the illness). Over one third of the cost is borne by sufferers and their carers. Misdiagnosis and incorrect therapy are common. To date quantitative assessment of Schizophrenics has been impossible making this tool potentially invaluable. An accurate diagnostic test could facilitate earl ....Quantitative measurement of Schizophrenia using Electrovestibulography. Schizophrenia was estimated to cost approximately $1.85billion in 2001 (0.3% of GDP and nearly $50k for each of the 37,000 Australians with the illness). Over one third of the cost is borne by sufferers and their carers. Misdiagnosis and incorrect therapy are common. To date quantitative assessment of Schizophrenics has been impossible making this tool potentially invaluable. An accurate diagnostic test could facilitate earlier diagnosis, more accurate treatment plans, and prevention of debilitating psychotic episodes for the sufferer. By being able to monitor drug efficacy the community can benefit by reduced drug costs, confinement times and hastened new drug development. Read moreRead less
DEEP DRILLING OF THE HUMAN PLASMA PROTEOME. Like turning out city lights lets you see the faint stars more clearly - removal of high abundance proteins from human biofluids allows quantum leaps in biomarker discovery. This project will develop products that remove the biggest obstacle in proteomics - high abundance proteins (city lights). Cheap, efficient and routine removal of abundant proteins will amplify the power of ?cutting edge? proteomic technologies in the discovery of novel biomarkers ....DEEP DRILLING OF THE HUMAN PLASMA PROTEOME. Like turning out city lights lets you see the faint stars more clearly - removal of high abundance proteins from human biofluids allows quantum leaps in biomarker discovery. This project will develop products that remove the biggest obstacle in proteomics - high abundance proteins (city lights). Cheap, efficient and routine removal of abundant proteins will amplify the power of ?cutting edge? proteomic technologies in the discovery of novel biomarkers. This is possible because undiscovered low copy number biomarkers (faint stars) exist in human diagnostic fluids at levels far lower than current proteomic array detection limits.Read moreRead less
Building a Smart Diagnostic System for Low Back Ailments. This research will develop an early back ailment diagnostic system that will reduce the recurrence of low back pain, and hence reduce the cost to the health system. This is significant to the community from prevention of pain, to the health care system that spends billions of dollars combating this modern day ailment and towards the industry where the low back pain is the single largest reason for sick leave in Australia. It will also giv ....Building a Smart Diagnostic System for Low Back Ailments. This research will develop an early back ailment diagnostic system that will reduce the recurrence of low back pain, and hence reduce the cost to the health system. This is significant to the community from prevention of pain, to the health care system that spends billions of dollars combating this modern day ailment and towards the industry where the low back pain is the single largest reason for sick leave in Australia. It will also give rise to employment of skilled technical people and an opportunity to increase high-value exports from Australia.Read moreRead less